DailyDoctor Archive Specialties Get app
Back to the 6 October 2026 edition

Research · 03 of 06

GDF-15 predicts death far better than it diagnoses obstructive coronary disease

Do not rely on GDF-15 to diagnose coronary disease; it may be a useful risk marker, but it should not change management on its own.

Design
Prospective cohort with central adjudication and 5-year follow-up
Population
3,379 patients with suspected functionally relevant coronary artery disease; median age 68
Primary outcome
Diagnosis of functionally relevant coronary disease; all-cause and cardiovascular death
Effect
Diagnostic AUC 0.598 (0.659 with clinical judgement); 2-year prognostic AUC 0.815 (all-cause) and 0.834 (cardiovascular death)

In this prospective cohort, 3,379 patients (median age 68, 33% women, 44% with known coronary disease) had myocardial perfusion imaging and, when available, angiography with fractional flow reserve. Functionally relevant coronary disease was centrally adjudicated in 1,160 (34%).

Growth differentiation factor 15 was higher in those with the diagnosis (1,325 vs 1,041 ng/L), but diagnostic accuracy was modest, with an area under the curve of 0.598, rising to 0.659 when combined with clinical judgement. Prognostically it performed far better. Over 5 years, 437 patients (14%) died, 231 from cardiovascular causes, and time-dependent AUCs at 2 years were 0.815 for all-cause and 0.834 for cardiovascular death, at least comparable to high-sensitivity troponin T and higher than troponin I.

GDF-15 is not a routine test in most hospitals, and the study does not show that acting on a high value improves outcomes. It is an indication that the marker tracks overall frailty and risk better than it locates a coronary lesion.

  • Do not use GDF-15 to decide whether chest pain is due to obstructive coronary disease.
  • Treat a high level, if measured, as a general risk signal and review risk factors and frailty.
  • Continue to use functional testing or imaging for the diagnosis.
  • Check local availability before planning to use it; it is not a standard test.

Why it matters

It separates two jobs a biomarker can do, diagnosis and prognosis, and shows this one does only the second.

Don't overread it

Good prognostic accuracy does not mean that measuring or lowering GDF-15 improves survival.

The statistics, in plain English

An area under the curve of 0.5 is a coin toss and 1.0 is perfect. At 0.598, GDF-15 barely discriminates for the diagnosis; at about 0.82 to 0.83 it discriminates well for death at 2 years.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

evidenceinpatienttransitionsdiagnosis

Tomorrow morning, before your first patient

One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app